SmartTab is pleased to announce that the SXSW PanelPicker® has opened for community voting from August 10 through August 26, 2021. This is your chance to browse the many forward-thinking speaking proposals from some of the world’s most innovative minds.
SmartTab has proposed an innovative, interdisciplinary session highlighting many movements in technology and industry, "Wireless Ingestible Technologies." SmartTab Founder and CEO, Robert Niichel will discuss exciting advancements open to all interested in health/med tech, healthcare, and more!
About the Session
The convergence of wireless communications and ingestible systems has the potential to usher in a new era of monitoring and delivery of medicine. Access data from a most recent preclinical study of a device that can administer active ingredients via radio frequency at a targeted area inside the body and send real-time data to a physician. This session will examine the multiple layers that weave together the inevitable breakthroughs to come in remote patient monitoring, optimizing clinical efficacy, and the personalized patient experience. Get to know the companies that are moving the next decade of technology from outside to inside the human body to transform how we diagnose and treat chronic disease.
Session participants will:
- Learn about the basic design, development, testing, and published research of inductively-powered, preclinical wireless drug capsules.
- Examine how Wireless Body Area Networks (WBAN) connect the technology with AI, wearables, and the IoMT.
- Discover what ingestible technology could hold for the future: where it is now and where it is going.
Vote for SmartTab
The deadline to vote is August 26!
Based in Denver, Colorado, SmartTab is engaged in the design, development and validation of next generation wireless drug delivery systems. The SmartTab technology platform is a personalized wireless solution comprised of an ingestible capsule with a microprocessor, smart polymer actuator, and active ingredients. SmartTab is on a mission to provide novel effective therapies to improve patient outcomes and compliance.